The city's lame response shows, yet again, why we need more cooperation among local governments.
Mar 28, 2010 Pittsburgh Post-Gazette
Stuart Olmsted is director of operations for research and analysis and a senior natural scientist at the RAND Corporation. He works on science and technology policy issues in education and health. Olmsted's recent research includes measuring laboratory capacity to respond to bioterrorism attacks and pandemic influenza outbreaks, assessing the capacity of public health laboratories in resource-limited settings, and evaluating the U.S. military's serum repository. Prior to joining RAND, he taught high school math and chemistry in Baltimore City and was an officer in the U.S. Navy for five years.
Olmsted received his Ph.D. in biophysics from Johns Hopkins University and completed a postdoctoral fellowship at the Magee-Women's Research Institute.
Stuart S. Olmsted et al., "Patient Experience with, and Use of, an Electronic Monitoring System to Assess Vaccination Responses," Health Expectations, 9(2), 2006
Mickey Urdea et al., "Requirements for High Impact Diagnostics in the Developing World," Nature, 444, 2006
Stuart S. Olmsted et al., "Use of an Electronic Monitoring System for Self-Reporting Smallpox Vaccine Reactions," Biosecurity and Bioterrorism: Biodefense Strategy
Girosi F, Olmsted SS, Keeler E, Hay Burgess DC, Lim YW, Aledort JE, Rafael ME, Ricci KA, Boer R, Hilborne L, Derose KP, Shea MV, Beighley CM, Dahl CA, Wasserman J., "Developing and interpreting models to improve diagnostics in developing countries," Nature, 23(444), 2006
Moore M, Eiseman E, Fisher G, Olmsted S, Sama P, Zambrano J., Harnessing Full Value from the DoD Serum Repository and the Defense Medical Surveillance System, RAND Corporation (MG-875-A), 2010
Pane JF, VL Williams, SS Olmsted, K Yuan, E Spindler, ME Slaughter., Math Science Partnership of Southwest Pennsylvania: Measuring Progress Towards Goals., RAND Corporation (MG-857-AIU), 2009
Elisa Eiseman et al., Case Studies of Existing Human Tissue Repositories: Best Practices for a Biospecimen Resource for the Genomic and Proteomic Era, RAND Corporation (MG-120), 2003